Junbiao Wang

418 total citations
15 papers, 273 citations indexed

About

Junbiao Wang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Junbiao Wang has authored 15 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Immunology. Recurrent topics in Junbiao Wang's work include RNA Interference and Gene Delivery (3 papers), Immunotherapy and Immune Responses (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Junbiao Wang is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), Immunotherapy and Immune Responses (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Junbiao Wang collaborates with scholars based in Italy, Austria and Israel. Junbiao Wang's co-authors include Cristina Marchini, Augusto Amici, Martina Tilio, Valentina Gambini, Sergio Occhipinti, María Zabaleta, Barbara Belletti, Emiliano Laudadio, Daniela Pozzi and Roberta Galeazzi and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Cancer Letters.

In The Last Decade

Junbiao Wang

14 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junbiao Wang Italy 10 179 70 47 29 26 15 273
Mohammad Ali Mazlomi Iran 8 122 0.7× 38 0.5× 40 0.9× 16 0.6× 15 0.6× 17 255
Rodrigo Vargas Eguez United States 8 292 1.6× 27 0.4× 27 0.6× 17 0.6× 26 1.0× 9 399
Sishir K. Kamalapuram Australia 8 191 1.1× 38 0.5× 67 1.4× 9 0.3× 42 1.6× 10 333
Chetna Sharon United States 11 165 0.9× 27 0.4× 41 0.9× 14 0.5× 31 1.2× 16 382
Guangsen Fu United States 8 325 1.8× 32 0.5× 36 0.8× 36 1.2× 28 1.1× 11 386
Chaoqun Lian China 11 232 1.3× 74 1.1× 45 1.0× 8 0.3× 8 0.3× 49 327
Idris O. Raji United States 11 331 1.8× 25 0.4× 37 0.8× 12 0.4× 55 2.1× 17 482
Qiao Duan China 9 296 1.7× 14 0.2× 26 0.6× 23 0.8× 25 1.0× 14 382
Chih‐Hsiang Chang Taiwan 13 178 1.0× 19 0.3× 54 1.1× 12 0.4× 47 1.8× 22 347
Dulla Naveen Kumar India 12 271 1.5× 105 1.5× 52 1.1× 16 0.6× 31 1.2× 25 483

Countries citing papers authored by Junbiao Wang

Since Specialization
Citations

This map shows the geographic impact of Junbiao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbiao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbiao Wang more than expected).

Fields of papers citing papers by Junbiao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junbiao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbiao Wang. The network helps show where Junbiao Wang may publish in the future.

Co-authorship network of co-authors of Junbiao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Junbiao Wang. A scholar is included among the top collaborators of Junbiao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junbiao Wang. Junbiao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Huang, Xiaohui, Franks Kamgang Nzekoue, Junbiao Wang, et al.. (2025). A Study of Bioactivities and Composition of a Cocktail of Supernatants Derived from Lactic Acid Bacteria for Potential Food Applications. Probiotics and Antimicrobial Proteins. 17(6). 5012–5029. 2 indexed citations
2.
Spinozzi, Eleonora, Marco Cespi, Riccardo Petrelli, et al.. (2025). Hydrogels Powered by Nanoemulsion Technology for the Topical Delivery of Acmella oleracea Extract. Pharmaceutics. 17(5). 625–625.
3.
Wang, Junbiao, Daniela Beghelli, Augusto Amici, et al.. (2024). Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer. Biomolecules. 14(11). 1454–1454. 3 indexed citations
4.
Musa, Sanaa, et al.. (2024). Overcoming Chemoresistance in Cancer: The Promise of Crizotinib. Cancers. 16(13). 2479–2479. 12 indexed citations
5.
Wang, Junbiao, Fiorenza Orlando, Robertina Giacconi, et al.. (2024). Enhancing Immune Responses against SARS-CoV-2 Variants in Aged Mice with INDUK: A Chimeric DNA Vaccine Encoding the Spike S1-TM Subunits. ACS Omega. 9(32). 34624–34635. 1 indexed citations
6.
Andreani, Cristina, Caterina Bartolacci, Francesca Casciaro, et al.. (2023). SIRT6 promotes metastasis and relapse in HER2-positive breast cancer. Scientific Reports. 13(1). 22000–22000. 11 indexed citations
7.
Digiacomo, Luca, Junbiao Wang, Augusto Amici, et al.. (2023). Insights into the effect of polyethylene terephthalate (PET) microplastics on HER2 signaling pathways. Toxicology in Vitro. 91. 105632–105632. 12 indexed citations
8.
Quagliarini, Erica, Luca Digiacomo, Heinz Amenitsch, et al.. (2022). Efficient Delivery of DNA Using Lipid Nanoparticles. Pharmaceutics. 14(8). 1698–1698. 34 indexed citations
9.
Galassi, Rossana, Junbiao Wang, Silvia Vincenzetti, et al.. (2022). Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules. Biomolecules. 12(1). 80–80. 9 indexed citations
10.
Quagliarini, Erica, Luca Digiacomo, Francesca Giulimondi, et al.. (2021). Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery. Pharmaceutics. 13(8). 1292–1292. 34 indexed citations
11.
Wang, Junbiao, Romilde Iannarelli, Stefania Pucciarelli, et al.. (2020). Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice. Pharmacological Research. 161. 105123–105123. 15 indexed citations
12.
Falconi, Maurizio, Mara Giangrossi, María Zabaleta, et al.. (2019). A novel 3'‐tRNA Glu ‐derived fragment acts as a tumor suppressor in breast cancer by targeting nucleolin. The FASEB Journal. 33(12). 13228–13240. 72 indexed citations
13.
Gambini, Valentina, Martina Tilio, Cristina Andreani, et al.. (2018). In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer. European Journal of Medicinal Chemistry. 155. 418–427. 20 indexed citations
14.
Bartolacci, Caterina, Cristina Andreani, Claudia Curcio, et al.. (2018). Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer. Cancer Immunology Research. 6(12). 1486–1498. 28 indexed citations
15.
Tilio, Martina, Valentina Gambini, Junbiao Wang, et al.. (2016). Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib. Cancer Letters. 381(1). 76–84. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026